TAUNS Laboratories, Inc. Logo

TAUNS Laboratories, Inc.

Develops and sells in vitro diagnostics and research reagents, like antigen tests, globally.

197A | T

Overview

Corporate Details

ISIN(s):
JP3452250008
LEI:
Country:
Japan
Address:
伊豆の国市神島761番1
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

TAUNS Laboratories, Inc., founded in 1987, is a company engaged in the development, manufacture, and sale of in vitro diagnostics (IVD) and research reagents. The company's mission is to enrich lives and provide peace of mind through its proprietary diagnostic technologies. Its main products include antigen test kits for infectious diseases and various analytical reagents. A key focus for the company is the development of patient-friendly products for global consumption, facilitated through its export and import operations.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-25 09:49
Registration Form
確認書
Japanese 8.1 KB
2025-09-25 09:47
Annual Report
有価証券報告書-第10期(2024/07/01-2025/06/30)
Japanese 2.0 MB
2025-02-13 07:30
Report Publication Announcement
確認書
Japanese 8.0 KB
2025-02-13 07:30
Interim Report
半期報告書-第10期(2024/07/01-2025/06/30)
Japanese 174.5 KB
2024-09-30 03:19
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-09-27 08:00
Registration Form
確認書
Japanese 8.1 KB
2024-09-27 08:00
Governance Information
内部統制報告書-第9期(2023/07/01-2024/06/30)
Japanese 22.1 KB
2024-09-27 08:00
Annual Report
有価証券報告書-第9期(2023/07/01-2024/06/30)
Japanese 1.9 MB
2024-06-12 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-06-04 08:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-05-17 08:00
Registration Form
有価証券届出書(新規公開時)
Japanese 4.7 MB

Automate Your Workflow. Get a real-time feed of all TAUNS Laboratories, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TAUNS Laboratories, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TAUNS Laboratories, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.
South Korea
052670
Chemical Works of Gedeon Richter Plc Logo
Develops and manufactures drugs for women's health, CNS, and cardiovascular diseases.
Hungary
RICHT
Chemomab Therapeutics Ltd. Logo
Develops antibody drugs neutralizing CCL24 for severe fibro-inflammatory diseases.
United States of America
CMMB
CHINA PHARMA HOLDINGS, INC. Logo
Develops, manufactures, and sells prescription, OTC, and nutritional products for human use.
United States of America
CPHI
China SXT Pharmaceuticals, Inc. Logo
Researches, produces, and sells advanced Traditional Chinese Medicine (TCM) herbal products.
United States of America
SXTC
ChoA Pharmaceutical Co., LTD. Logo
Global manufacturer of OTC medicines and health supplements distributed through pharmacies.
South Korea
034940
CHUGAI PHARMACEUTICAL CO., LTD. Logo
An R&D pharma leader in Japan creating innovative drugs via antibody engineering technology.
Japan
4519
Cinclus Pharma Holding AB Logo
Clinical-stage pharma developing a next-gen P-CAB drug for severe GERD patients.
Sweden
CINPHA
Cingulate Inc. Logo
Developing once-daily, precision timed-release drugs for ADHD and anxiety.
United States of America
CING
Circio Holding ASA Logo
Developing circular RNA vector tech and immunotherapies for gene and cell therapies.
Norway
CRNA

Talk to a Data Expert

Have a question? We'll get back to you promptly.